Our team specializes in providing premier Biometrics services for Data Monitoring Committee (DMC) requirements in clinical trials. With an established team of seasoned experts, we are dedicated to supporting leading pharmaceutical companies and Contract Research Organizations (CROs) with their resourcing needs. Our commitment to excellence and deep expertise in data monitoring ensures that your clinical data conforms to the highest standards of quality and integrity.
Intego's statistical programmers and biostatisticians provide exceptional precision in data analysis and reporting, ensuring the safety, scientific validity, and integrity of clinical trial data. DMCs are vital for trials with significant safety concerns, risks, or complexities, offering independent assessments to protect both current and future patients. By partnering with Intego, sponsors and CROs can be confident that their clinical trials are conducted with the highest standards of patient safety and data integrity.
We provide a full range of analyses tailored to the specific needs of Data Monitoring Committees in clinical trials, including safety monitoring through regular review of adverse events and safety data, rigorous efficacy analysis to ensure trials meet their endpoints, and interim analyses to assess the progress and viability of ongoing trials. Additionally, we ensure all data monitoring activities follow regulatory guidelines and standards.
Our team is our greatest asset. We have assembled a group of highly skilled professionals with extensive experience in clinical trials and DMC analyses. Our experts bring a wealth of knowledge in statistical methodology, programming, and data analysis, ensuring robust and reliable results. Their expertise in handling complex data and their commitment to maintaining the highest standards of quality make us a trusted FSP partner for prominent life science companies. Our team is dedicated to providing exceptional support and guidance throughout the entire clinical trial process, ensuring the success and integrity of your studies.
Our biostatisticians and statistical programmers have extensive experience supporting DMCs in a variety of therapeutic areas and logistical scenarios. We understand the challenges of providing analyses for interim decision-making on incomplete and often unclean data. Our team is adept at ensuring data quality and aligning DMC and main study analyses. This expertise allows us to effectively support your studies, regardless of their complexity.
Our partners trust us to provide: